Therapy: Cardiovascular safety of celecoxib, naproxen and ibuprofen

Nat Rev Rheumatol. 2017 Mar;13(3):136-138. doi: 10.1038/nrrheum.2017.4. Epub 2017 Jan 27.

Author

Michael T Nurmohamed¹

Affiliation

¹ Amsterdam Rheumatology and Immunology Center, Department of Rheumatology, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, Netherlands.

PMID: 28127041
DOI: 10.1038/nrrheum.2017.4

No abstract available

Publication types

Comparative Study

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Cardiovascular System / drug effects*
Celecoxib / administration & dosage
Celecoxib / adverse effects*
Celecoxib / therapeutic use
Clinical Trials as Topic
Cyclooxygenase 2 Inhibitors / adverse effects
Cyclooxygenase 2 Inhibitors / therapeutic use
Humans
Ibuprofen / administration & dosage
Ibuprofen / adverse effects*
Ibuprofen / therapeutic use
Naproxen / administration & dosage
Naproxen / adverse effects*
Naproxen / therapeutic use
Osteoarthritis / drug therapy
Outcome Assessment, Health Care
Safety / statistics & numerical data*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase 2 Inhibitors
Naproxen
Celecoxib
Ibuprofen